|
|
Very long-term outcome of acute promyelocytic leukemia after treatment wtih all trans retinoic acid and chemotherapy: the European APL Group experience.
Lionel Ades
,
Agnes Guerci
,
Emmanuel Raffoux
,
Miguel Sanz
,
Patrice Chevallier
et al.
Article dans une revue
hal-00453230v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA
Lining Wang
,
Emmanuel Raffoux
,
Xavier Thomas
,
Ibrahim Yakoub-Agha
,
Jean-Henri Bouhris
et al.
Article dans une revue
hal-01557470v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.
Xavier Thomas
,
Stéphane de Botton
,
Sylvie Chevret
,
Denis Caillot
,
Emmanuel Raffoux
et al.
Article dans une revue
hal-01557436v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.
Juliette Lambert
,
Cécile Pautas
,
Christine Terré
,
Emmanuel Raffoux
,
Pascal Turlure
et al.
Article dans une revue
hal-01984959v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|